Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ROSE BIDCO AS
AS
Active
Org 931050818
Haakon Viis Gate 1, 0161 Oslo
Medical specialists activities · NACE 8622
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
+81% vs 2023
Equity ratio
72.1%
Financial strength
Net profit 2024
NOK -13,3M
-40% vs 2023
EBITDA — year on year
NOK millions
0M
-2M
-4M
-6M
-8M
-6M
2023
-1M
+83%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -1,1M
+81%
Net profit
NOK -13,3M
-40%
Total assets
NOK 444,6M
+1%
Equity
NOK 320,4M
+6%
Employees
0
—
Company information
Legal name
ROSE BIDCO AS
Org number
931050818
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
17. mars 2023
Share capital
NOK 75 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Å være investeringsselskap, samt det som står i naturlig forbindelse med dette.
Contact
Address
Haakon Viis Gate 1, 0161 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
-6M
2023
-1M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−6 042
−1 144
Depreciation & amort.
−0
−0
EBIT
−6 042
−1 144
Net financials
−4 853
−15 846
Profit before tax
−10 895
−16 990
Tax
−1 421
−3 738
Net profit
−9 474
−13 252
Balance sheet
NOK thousands
Item
2023
2024
Total assets
442 298
444 613
Equity
303 608
320 356
Long-term debt
131 037
118 223
Short-term debt
7 653
6 034
Total debt
138 690
124 257
Financial ratios
5-year trend
EBITDA margin
-114405300.0%
This company
15.8%
Market median
-724084277% vs market
2023
2024
Equity ratio
72.1%
This company
38.2%
Market median
+89% vs market
2023
2024
Return on equity
-4.1%
This company
18.4%
Market median
-122% vs market
2023
2024
Net profit margin
-1325204500.0%
This company
8.1%
Market median
-16360549483% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-02-28 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
FT
Fredrik Toft Bysveen
Chairman
2023
MF
Morten Faye Eriksen
Board of Directors
2025
Former (2)
KB
Kristian Brekke Djuve
Chairman
2023 – 2023
FL
Fredrik Lundervold Kongsli
Board of Directors
2023 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Rose Midco As
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Runa As
Rose Midco As
ROSE BIDCO AS
(this company)
Medicus Group As
MEDICUS BERGEN AS
MEDICUS OSLO AS
MEDICUS STAVANGER AS
MEDICUS TRONDHEIM AS
Board network connections
Board members of ROSE BIDCO AS also hold positions in
0
other companies.
Person
Role here
Other companies
Fredrik Toft Bysveen
Chairman
0 companies
Kristian Brekke Djuve
Chairman
0 companies
Fredrik Lundervold Kongsli
Board of Directors
0 companies
Morten Faye Eriksen
Board of Directors
0 companies